| Stage | MDT | % of rev | TMDX | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $9.8B | 100.00% | $190M | 100.00% | MDT ×51.36 |
| Gross profit | $6.3B | 64.99% | $113M | 59.59% | MDT +5.4pp |
| Operating income | $1.8B | 18.08% | $24M | 12.50% | MDT +5.6pp |
| Pre-tax income | $1.8B | 18.13% | $19M | 10.22% | MDT +7.9pp |
| Net income | $1.5B | 15.16% | $15M | 7.73% | MDT +7.4pp |
| Stage | MDT | TMDX | Gap · A − B |
|---|---|---|---|
| Revenue | $9.8B100.00% | $190M100.00% | MDT ×51.36 |
| Gross profit | 64.99%$6.3B | 59.59%$113M | MDT +5.4pp |
| Operating income | 18.08%$1.8B | 12.50%$24M | MDT +5.6pp |
| Pre-tax income | 18.13%$1.8B | 10.22%$19M | MDT +7.9pp |
| Net income |
| 15.16%$1.5B |
| 7.73%$15M |
| MDT +7.4pp |
No shared counterparties.